Vivienne I Rebel is Chief Sci. & Med. Officer, EVP of bioAffinity Technologies, Inc.. Currently has a direct ownership of 46,228 shares of BIAF, which is worth approximately $56,860. The most recent transaction as insider was on Jan 31, 2024, when has been sold 31,847 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.2K
0% 3M change
221.45% 12M change
Total Value Held $56,860

Vivienne I Rebel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2024
BUY
Grant, award, or other acquisition
-
31,847 Added 40.79%
46,228 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
7,239 Added 33.48%
14,381 Common Stock, par valu...
VIR

Vivienne I Rebel

Chief Sci. & Med. Officer, EVP
San Antonio, TX

Track Institutional and Insider Activities on BIAF

Follow bioAffinity Technologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIAF shares.

Notify only if

Insider Trading

Get notified when an Bio Affinity Technologies, Inc. insider buys or sells BIAF shares.

Notify only if

News

Receive news related to bioAffinity Technologies, Inc.

Track Activities on BIAF